Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$27,000.00
The Effects of Chronic AMPK Activation on Aged Neuromuscular Junction Morphology and Health
FY 2024-25
Summary
(Background): The neuromuscular junction (NMJ) is the chemical bridge connecting our peripheral nervous system to our skeletal muscle system, facilitating the translation of neuronal impulses into muscular contraction. Furthermore, it is this structure that is subject to morphological deterioration within neuromuscular diseases and the aged-related loss of muscle mass or sarcopenia. Literature has documented the effects of protein knockout and upregulation on NMJ morphology/health; common to these proteins are their regulation via AMPK. Muscle-specific knockout of it leads to a prematurely aged NMJ phenotype, conversely, conditions that would elicit its indirect activation show morphological improvements. Coupled with the idea that AMPK signalling is blunted with age (Purpose): we are interested in utilizing an AMPK activator to investigate the direct effects of AMPK upregulation on aged neuromuscular junction morphology and health. (Methods): At 18-months of age C57BL/6 mice will undergo a 6-month dosing intervention. They will be randomized into drug (MK) or control (ctrl) groups receiving either 10 mg/kg of the AMPK small molecule activator MK8722 or vehicle respectively. At 2-month increments, alongside mice aged 3-months (young-ctrl) they will perform functional tests to (Question 1): investigate whether age-related functional declines will be improved with upregulated AMPK activation across 0, 2, 4, and 6-month time points. At the end of the intervention ETA muscles will be collected, NMJ pre- and post-synaptic compartments confocally imaged, and analyzed via the ImageJ software. Quantifying the characteristics of NMJ morphology we will (Question 2): investigate whether NMJ deterioration associated with age will be improved with AMPK activator.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530032
Name
Hong Ricky K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Effects of Chronic AMPK Activation on Aged Neuromuscular Junction Morphology and Health
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adenosine Monophosphate Activated Protein Kinase (Ampk); Aging; Exercise Physiology; Mk8722; Molecular Signalling; Murine Model; Neuromuscular Junction (Nmj); Neuromuscular Physiology; Sarcopenia; Skeletal Muscle Health
Abstract
(Background): The neuromuscular junction (NMJ) is the chemical bridge connecting our peripheral nervous system to our skeletal muscle system, facilitating the translation of neuronal impulses into muscular contraction. Furthermore, it is this structure that is subject to morphological deterioration within neuromuscular diseases and the aged-related loss of muscle mass or sarcopenia. Literature has documented the effects of protein knockout and upregulation on NMJ morphology/health; common to these proteins are their regulation via AMPK. Muscle-specific knockout of it leads to a prematurely aged NMJ phenotype, conversely, conditions that would elicit its indirect activation show morphological improvements. Coupled with the idea that AMPK signalling is blunted with age (Purpose): we are interested in utilizing an AMPK activator to investigate the direct effects of AMPK upregulation on aged neuromuscular junction morphology and health. (Methods): At 18-months of age C57BL/6 mice will undergo a 6-month dosing intervention. They will be randomized into drug (MK) or control (ctrl) groups receiving either 10 mg/kg of the AMPK small molecule activator MK8722 or vehicle respectively. At 2-month increments, alongside mice aged 3-months (young-ctrl) they will perform functional tests to (Question 1): investigate whether age-related functional declines will be improved with upregulated AMPK activation across 0, 2, 4, and 6-month time points. At the end of the intervention ETA muscles will be collected, NMJ pre- and post-synaptic compartments confocally imaged, and analyzed via the ImageJ software. Quantifying the characteristics of NMJ morphology we will (Question 2): investigate whether NMJ deterioration associated with age will be improved with AMPK activator.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hong, Ricky K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~